Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab

2019

Purpose We performed a cross-sectional study of neurocognitive function in non-brain cancer patients treated with long-term bevacizumab.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

31

References

0

Citations